Back to search
FDAFDA · Food and drugs·Recall number D-0337-2015

Gabapentin Capsules, USP, 300 mg, Rx Only, 100 capsules per bottle, Manufactured by: Actavis Pharma Manufacturing Pvt. Ltd., Plot No 101, 102, 107, & 108, SIDCO Pharmaceutical Complex, Alathurt, Kanchipuram Dist-603 110, Tamlinadu, India, Distributed by: Actavis Elizabeth LLC, 700 Elmora Ave, Elizabeth, NJ 07207 USA, NDC 45963-556-11

Published January 14, 2015 · Recall initiated: December 15, 2014

Summary

FDA records drug Class II recall D-0337-2015, published January 14, 2015 and initiated December 15, 2014. Recalling firm: Actavis Elizabeth LLC; Status: Terminated; Reported quantity: 24,240 Bottles; Lot: Lot #s: G01960A1, Exp 09/2015, G01967A1, Exp 10/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.

What to do

Voluntary: Firm initiated · Letter

Get an email if GABA 300-EZS has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
GABA 300-EZS
Manufacturer
Actavis Elizabeth LLC
Distributor
Puerto Rico
UPC
0731477272217
Lot
Lot #s: G01960A1, Exp 09/2015, G01967A1, Exp 10/2015
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Gabapentin Capsules, USP, 300 mg, Rx Only, 100 capsules per bottle, Manufactured by: Actavis Pharma Manufacturing Pvt. Ltd., Plot No 101, 102, 107, & 108, SIDCO Pharmaceutical Complex, Alathurt, Kanchipuram Dist-603 110, Tamlinadu, India, Distributed by: Actavis Elizabeth LLC, 700 Elmora Ave, Elizabeth, NJ 07207 USA, NDC 45963-556-11 recalled?

Yes. FDA published recall D-0337-2015 on January 14, 2015. Reported hazard: Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: GABA 300-EZS. UPC: 0731477272217.